Empery Asset Management, LP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Empery Asset Management, LP has filed 470 SEC EDGAR filings since 31 Jul 2009

SEC filing history

Showing 251-275 of 467 matching filings.

Per page
25
Current page
11
SC 13G

TITAN PHARMACEUTICALS, INC.

Filing date
22 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BENITEC BIOPHARMA, LIMITED

Filing date
07 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

OCUGEN, INC.

Filing date
07 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

AETERNA ZENTARIS INC.

Filing date
25 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

NOVABAY PHARMACEUTICALS, INC.

Filing date
15 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

OBALON THERAPEUTICS, INC.

Filing date
06 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

AMPIO PHARMACEUTICALS, INC.

Filing date
20 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

DELMAR PHARMACEUTICALS, INC.

Filing date
05 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PULMATRIX, INC.

Filing date
15 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ADVAXIS, INC

Filing date
12 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

INSPIREMD, INC.

Filing date
10 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

XENETIC BIOSCIENCES, INC

Filing date
11 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

TRILLIUM THERAPEUTICS INC.

Filing date
04 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ADIAL PHARMACEUTICALS, INC.

Filing date
01 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

PULMATRIX, INC.

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

TARONIS TECHNOLOGIES, INC.

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

STAFFING 360 SOLUTIONS, INC.

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

VALERITAS HOLDINGS, INC.

Filing date
05 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

INTELLIPHARMACEUTICS INTERNATIONAL INC.

Filing date
01 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

ENER-CORE, INC.

Filing date
31 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

BIOPHARMX CORPORATION

Filing date
29 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

IMMURON LIMITED

Filing date
29 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BIO-PATH HOLDINGS, INC.

Filing date
24 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BIOCEPT, INC.

Filing date
24 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

KITOV PHARMA, LTD.

Filing date
24 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .